Compliance with prospective trial registration guidance remained low in high-impact journals and has implications for primary end point reporting

Journal of Clinical Epidemiology

Volumn 75, Issue , 2016, Pages 100-107

  Dal Ré, Rafael ^a   Ross, Joseph S ^b,c   Marušić, Ana ^d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b YALE UNIVERSITY   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

^d UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Clinical trials; Compliance; ICMJE; Journal editors; Nonregulated intervention trials; Policy; Prospective registration

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); FOOD AND DRUG ADMINISTRATION; HUMAN; OUTCOME ASSESSMENT; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PUBLISHING; REGISTRATION; SCIENTIFIC LITERATURE; ADVISORY COMMITTEE; EPIDEMIOLOGY; JOURNAL IMPACT FACTOR; PROSPECTIVE STUDY; PUBLICATION; RESEARCH; STATISTICS AND NUMERICAL DATA;

ADVISORY COMMITTEES; EDITORIAL POLICIES; EPIDEMIOLOGIC RESEARCH DESIGN; GUIDELINES AS TOPIC; HUMANS; JOURNAL IMPACT FACTOR; PERIODICALS AS TOPIC; PROSPECTIVE STUDIES; RESEARCH REPORT;

EID: 84958231595     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.01.017     Document Type: Article

References (35)

1. [1] Moorthy, V.S., Karam, G., Vannice, K.S., Kieny, M.P., Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results. PLoS Med, 12, 2015, e1001819.
2. [2] Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risks. Available at http://www.iom.edu/Reports/2015/Sharing-Clinical-Trial-Data.aspx. Accessed December 19, 2015.
3. [3] Loder, E., Groves, T., The BMJ requires data sharing on request for all trials. BMJ, 350, 2015, h2373.
4. [4] Dickersin, K., Chalmers, I., Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO. J R Soc Med 104 (2011), 532–538.
5. [5] Scherer, R.W., Ugarte-Gil, C., Schmucker, C., Meerpohl, J.J., Authors report lack of time as main reason for unpublished research presented at biomedical conferences: a systematic review. J Clin Epidemiol 68 (2015), 803–810.
6. [6] Dwan, K., Altman, D.G., Cresswell, L., Blundell, M., Gamble, C.L., Williamson, P.R., Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database Syst Rev, 2011, MR000031.
7. [7] ICMJE. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. Updated December 2014. Available at http://www.icmje.org/icmje-recommendations.pdf. Accessed December 19, 2015.
8. [8] World Health Organization. International clinical trials registry platform (ICTRP). Available at http://www.who.int/ictrp/trial_reg/en/. Accessed December 19, 2015.
9. [9] Emdin, C., Odutayo, A., Hsiao, A., Shakir, M., Hopewell, S., Rahimi, K., et al. Association of cardiovascular trial registration with positive study findings: Epidemiological Study of Randomized Trials (ESORT). JAMA Intern Med 175 (2015), 304–307.
10. [10] Califf, R.M., Zarin, D.A., Kramer, J.M., Sherman, R.E., Aberle, L.H., Tasneem, A., Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 307 (2012), 1838–1847.
11. [11] Gill, C.J., How often do US-based human subjects research studies register on time, and how often do they post their results? A statistical analysis of the Clinicaltrials.gov database. BMJ Open, 2, 2012, e001186.
12. [12] Huser, V., Cimino, J.J., Evaluating adherence to the International Committee of Medical Journal Editors' policy of mandatory, timely clinical trial registration. J Am Med Inform Assoc 20 (2013), e169–e174.
13. [13] Jones, C.W., Platts-Mills, T.F., Quality of registration for clinical trials published in emergency medicine journals. Ann Emerg Med 60 (2012), 458–464.
14. [14] van Lent, M., IntHout, J., Out, H.J., Differences between information in registries and articles did not influence publication acceptance. J Clin Epidemiol 68 (2015), 1059–1067.
15. [15] Huic, M., Marušić, M., Marušić, A., Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy. PLoS One, 6, 2011, e25258.
16. [16] De Angelis, C., Drazen, J.M., Frizelle, F.A., Haug, C., Hoey, J., Horton, R., et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med 141 (2004), 477–478.
17. [17] Annals of Internal Medicine. Information for authors. Available at http://annals.org/public/authorsinfo.aspx. Accessed December 19, 2015.
18. [18] PLOS Medicine. Guidelines for authors. Available at http://journals.plos.org/plosmedicine/s/submission-guidelines. Accessed December 19, 2015.
19. [19] BioMed Central. Editorial policies. Available at http://www.biomedcentral.com/about/editorialpolicies. Accessed December 19, 2015.
20. [20] All Trials initiative. Available at http://www.alltrials.net/. Accessed December 19, 2015.
21. [21] Hartung, D.M., Zarin, D.A., Guise, J.M., McDonagh, M., Paynter, R., Helfand, M., Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann Intern Med 160 (2014), 477–483.
22. [22] Becker, J.E., Krumholz, H.M., Ben-Josef, G., Ross, J.S., Reporting of results in ClinicalTrials.gov and high-impact journals. JAMA 311 (2014), 1063–1065.
23. [23] Malički, M., Marušić, A., OPEN (to Overcome failure to Publish nEgativefiNdings) Consortium. Is there a solution to publication bias? Researchers call for changes in dissemination of clinical research results. J Clin Epidemiol 67 (2014), 1103–1110.
24. [24] Hooft, L., Korevaar, D.A., Molenaar, N., Bossuyt, P.M., Scholten, R.J., Endorsement of ICMJE's Clinical Trial Registration Policy: a survey among journal editors. Neth J Med 72 (2014), 349–355.
25. [25] Dal-Ré, R., Caplan, A.L., Time to ensure that clinical trial appropriate results are actually published. Eur J Clin Pharmacol 70 (2014), 491–493.
26. [26] Journal of Clinical Oncology. Information for contributors. Available at http://jco.ascopubs.org/site/ifc/manuscript-guidelines.xhtml. Accessed February 8, 2016.
27. [27] New England Journal of Medicine. For authors: author center. Available at www.nejm.org/page/author-center/supplementary-appendix. Accessed December 19, 2015.
28. [28] Bastian, H., Glasziou, P., Chalmers, I., Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?. PLoS Med, 7, 2010, e1000326.
29. [29] van de Wetering, F.T., Scholten, R.J., Haring, T., Clarke, M., Hooft, L., Trial registration numbers are underreported in biomedical publications. PLoS One, 7, 2012, e49599.
30. [30] Wager, E., Williams, P., Project Overcome failure to Publish nEgativefiNdings Consortium. “Hardly worth the effort”? Medical journals' policies and their editors' and publishers' views on trial registration and publication bias: quantitative and qualitative study. BMJ, 347, 2013, f5248.
31. [31] Dal-Ré, R., Bracken, M.B., Ioannidis, J.P., Call to improve transparency of trials of non-regulated interventions. BMJ, 350, 2015, h1323.
32. [32] Hudson, K.L., Collins, F.S., Sharing and reporting the results of clinical trials. JAMA 313 (2015), 355–356.
33. [33] NIH Request for Public Comments on the Draft NIH Policy on Dissemination of NIH-Funded Clinical Trial Information.NOT-OD-15-019. grants.nih.gov/grants/guide/notice-files/NOT-OD-15-019.html. Accessed December 19, 2015.
34. [34] COPE, Committee on publication ethics. Code of conduct and best practice guidelines for journal editors. 2011 Available at publicationethics.org Accessed December 19, 2015.
35. [35] CONSORT. Transparent reporting of trials. 2010 Available at http://www.consort-statement.org/consort-2010 Accessed December 19, 2015.